Advertisement

Cancer Immunology, Immunotherapy

, Volume 38, Issue 5, pp 287–293 | Cite as

Activation of tumor-infiltrating macrophages by a synthetic lipid A analog (ONO-4007) and its implication in antitumor effects

  • De Yang
  • Motonobu Satoh
  • Hiroshi Ueda
  • Shigeru Tsukagoshi
  • Masatoshi Yamazaki
Original Articles ONO-4007, Lipid A, Antitumor Effect, TNF, TIM

Abstract

ONO-4007 is a novel synthetic analog of lipid A subunit and has been shown to exert antitumor activities on various experimental tumors with less toxicity than lipopolysaccharide. It remains unclear, however, what biological activities of this compound are relevant to its antitumor effects. We therefore investigated the activation of macrophages by ONO-4007 in vitro and in vivo and its implication in antitumor effects, using mouse MM46 mammary tumor as an experimental model. Intravenous injection of ONO-4007 produced significant therapeutic effects on this solid tumor. ONO-4007 could stimulate glycogen-elicited peritoneal macrophages in vitro, not only to produce tumor necrosis factor (TNF), but also to exert cytocidal activities against MM46 cells in vitro. Substantial TNF production was induced in tumor tissue by i. v. injection of ONO-4007, and its successive administration to tumor-bearing mice gave tumor-infiltrating macrophages a prominent in vitro tumoricidal activity and primed them for in vitro TNF secretion. These results suggest that activation of tumor-infiltrating macrophages to a direct tumoricidal state as well as to TNF secretion in tumor tissues may be at least some of the antitumor effects of this novel lipid A analog.

Key words

ONO-4007 Lipid A Antitumor effect TNF TIM 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abe S, Yoshioka O, Masuko Y, Tsubouchi J, Kohno M, Nakajima H, Yamazaki M, Mizuno D (1982) Combination antitumor therapy with lentinan and bacterial lipopolysaccharide against murine tumors. Gann 73: 91PubMedGoogle Scholar
  2. 2.
    Abe S, Tubouchi J, Takahashi K, Yamazaki M, Mizuno D (1982) Combination therapy of murine tumors with lentinan plus lipopolysaccharide plus cyclophosphamide. Gann 73: 961PubMedGoogle Scholar
  3. 3.
    Barth RJ Jr, Muke JJ, Spiess PJ, Rosenberg SA (1991) Interferon gamma and tumor necrosis factor have a role in tumor regression mediated by murine CD8+ tumor-infiltrating lymphocytes. J Exp Med 173: 647PubMedGoogle Scholar
  4. 4.
    Branellec D, Chouaib S (1991) TNF: antitumoral agent at the borderlines of immunity and inflammation. Pathol Biol (Paris) 39: 230Google Scholar
  5. 5.
    Cameron DJ, Strimberg BV (1984) The ability of macrophages from head and neck cancer patients to kill tumor cells. Cancer 54: 2403PubMedGoogle Scholar
  6. 6.
    Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72: 3666PubMedGoogle Scholar
  7. 7.
    Conti P, Dempsey RA, Reale M, Barbacane RC, Panara MR, Bongrazio M, Mier JW (1991) Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumor necrosis factor and interleukin-6: effect of IL-1 receptor antagonist. Immunology 73: 450PubMedGoogle Scholar
  8. 8.
    Fulton AM (1988) Tumor-associated macrophages In: Heppner GH, Fulton AM (eds) Macrophages and cancer. CRC, Boca Raton, Fla, p 97Google Scholar
  9. 9.
    Itoh Y, Kohgo Y, Watanabe N, Kanisawa Y, Sakamaki S, Takahashi M, Hirayama Y, Ono H, Himeno T, Niitsu Y (1991) Human tumor-infiltrating lymphocytes transfected with tumor necrosis factor gene could augment cytotoxicity to autologous tumor cells. Jpn J Cancer Res 82: 1203PubMedGoogle Scholar
  10. 10.
    Johnson AG, Tomai MA, Chen Y, Odean M (1991) A comparison of the immunomodulating properties of two forms of monophosphoryl lipid A analogues. J Immunother 10: 398PubMedGoogle Scholar
  11. 11.
    Keller R, Bassetti S, Keist R, Muelsch A, Klauser S (1992) Induction of nitric oxide synthase is a necessary precondition for expression of tumor necrosis factor-independent tumoricidal activity by activated macrophages. Biochem Biophys Res Commun 184: 1364PubMedGoogle Scholar
  12. 12.
    Kriegler M, Perez C, DeFay K, Albert I, Lu SD (1988) A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53: 45PubMedGoogle Scholar
  13. 13.
    Kusama T, Soga T, Shioya E, Nakayama K, Nakajima H, Osada Y, Ono Y, Kusumoto S, Shiba T (1990) Synthesis and antitumor activity of lipid A analogs having a phosphonooxyethyl group with α- or β-configuration at position 1. Chem Pharmacol Bull 38: 3366Google Scholar
  14. 14.
    Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L (1992) The origin and function of tumor-associated macrophages. Immunol Today 13: 265PubMedGoogle Scholar
  15. 15.
    Mizuno D (1988) Endogenous and exogenous tumor necrosis factor therapy: EET therapy. In: Bonavida B, Gifford GE, Kirchner H, Old LJ (eds) Tumor necrosis factor/cachectin and related cytokines. Karger, Basel, p 210Google Scholar
  16. 16.
    Morrison DC, Ryan JL (1983) Bacterial endotoxin and host immune response. Adv Immunol 28: 293Google Scholar
  17. 17.
    Nakagawara A, Nathan CF (1983) A simple method for counting adherent cells: application to cultured human monocytes, macrophages and multinucleated giant cells. J Immunol Methods 56: 261PubMedGoogle Scholar
  18. 18.
    Nishizawa T, Okutomi T, Inagawa H, Morikawa A, Oshima H, Soma G, Mizuno D (1991) Intratumoral tumor necrosis factor induction in tumor-bearing mice by exogenous/endogenous tumor necrosis factor therapy as compared with systemic administration of various biologic response modifiers. Mol Biother 3: 224PubMedGoogle Scholar
  19. 19.
    North RJ, Havell EA (1988) The antitumor function of tumor necrosis factor (TNF). II. Analysis of the roles of endogenous TNF in endotoxin-induced hemorrhagic necrosis and regression of an established sarcoma. J Exp Med 167: 1086PubMedGoogle Scholar
  20. 20.
    Ogawa Y, Fujishima Y, Ishida H, Kiso M, Hasegawa A (1991) Synthesis of a novel series of 4-O-phosphono-d-glucosamine derivatives (lipid A subunit analogs) carrying the C-branched 2-tetradecylhexadexananoyl group. Carbohydr Res 220: 155Google Scholar
  21. 21.
    Ruff MR, Gifford GE (1980) Purification and physico-chemical characterization of rabbit tumor necrosis factor. J Immunol 125: 1671PubMedGoogle Scholar
  22. 22.
    Saiki I, Sato K, Yoo YC, Murata J, Yoneda J, Kiso M, Hasegawa A, Azuma I (1992) Inhibition of tumor-induced angiogenesis by the administration of recombinant interferon-γ followed by synthetic lipid A subunit analogue (GLA-60). Int J Cancer 51: 641PubMedGoogle Scholar
  23. 23.
    Satoh M, Inagawa H, Minagawa H, Kajikawa T, Oshima H, Abe S, Yamazaki M, Mizuno D (1986) Endogenous production of TNF in mice long after BCG sensitization. J Biol Response Mod 5: 117PubMedGoogle Scholar
  24. 24.
    Satoh M, Yamazaki M (1987) Glycoprotein receptors to wheat germ agglutinin on the surface of murine macrophages. J Pharmacobiodyn 10: 608PubMedGoogle Scholar
  25. 25.
    Satoh M, Inagawa H, Shimada Y, Soma G, Oshima H, Mizuno D (1987) Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin. J Biol Response Mod 6: 512PubMedGoogle Scholar
  26. 26.
    Shimizu T, Ohtsuka Y, Yanagihara Y, Akamatsu S, Ikeda K, Achiwa K (1992) Biological activity of chemically synthesized core sugar linked lipid A analog, heptose-(alpha-1–5)-2-keto-3-deoxyocturonic acid-(alpha-2–6) 2, 3-diacyloxyacyl-glucosamine-4-phosphate. Int J Immunopharmacol 14: 221PubMedGoogle Scholar
  27. 27.
    Somlyo B, Csanky E, Shi XM, Zhang YL, Kivats E, Boma-Liptak E, Nowotny AM, Tripodi D, Nowotny A (1992) Molecular requirements of endotoxin (ET) actions: changes in the immune adjuvant, TNF liberating and toxix properties of endotoxin during alkaline hydrolysis. Int J Immunopharmacol 14: 131PubMedGoogle Scholar
  28. 28.
    Stolfi VM, Milson JW, Finke JH, Fazio VW, Fiocchi C (1992) Resident research award: tumor necrosis factor alpha selectively enhances growth and cytotoxic activity of tumor-infiltrating lymphocytes from human colorectal cancer. J Surg Res 52: 39PubMedGoogle Scholar
  29. 29.
    Takahashi K, Watanuki Y, Yamazaki M, Abe S (1988) Local induction of a cytotoxic factor in a murine tumour by systemic administration of an antitumour polysaccharide, MGA. Br J Cancer 57: 170PubMedGoogle Scholar
  30. 30.
    Verstovsek S, Maccubin D, Ehrke MJ, Mihich E (1992) Tumoricidal activation of murine resident peritoneal macrophages by interleukin-2 and tumor necrosis factor alpha. Cancer Res 52: 3880PubMedGoogle Scholar
  31. 31.
    Yamazaki M, Okutomi T (1989) Augmentation of cytotoxin from murine bone marrow and peritoneal macrophages by tumor transplantation. Cancer Res 49: 352PubMedGoogle Scholar
  32. 32.
    Yamazaki M, Esumi-Kurisu M, Mizuno D (1982) Modulation and induction of mediator-dependent tumor lysis mediated by macrophages. In: Mizuno D, Cohn ZA, Takeya K, Ishida N (eds) Selfdefense mechanisms. Elsevier Biomedical. New York, p 295Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • De Yang
    • 1
  • Motonobu Satoh
    • 1
  • Hiroshi Ueda
    • 1
  • Shigeru Tsukagoshi
    • 2
  • Masatoshi Yamazaki
    • 1
  1. 1.Department of Medicinal Chemistry, Faculty of Pharmaceutical SciencesTeikyo UniversityKanagawaJapan
  2. 2.Cancer Chemotherapy CenterJapanese Foundation for Cancer ResearchTokyoJapan

Personalised recommendations